Envisioning a transformed clinical trials enterprise in the United States : establishing an agenda for 2020 : workshop summary /

"There is growing recognition that the United States' clinical trials enterprise (CTE) faces great challenges. There is a gap between what is desired - where medical care is provided solely based on high quality evidence - and the reality - where there is limited capacity to generate timel...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autores Corporativos: Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation, Institute of Medicine (U.S.). Board on Health Sciences Policy
Otros Autores: Weisfeld, Neil E., English, Rebecca A., Claiborne, Anne B.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press, ©2012.
Colección:Online access: National Academy of Sciences National Academies Press.
Online access: NCBI NCBI Bookshelf.
Temas:
Clinical trials > United States.
Clinical trials > Economic aspects > United States.
Clinical trials > Social aspects > United States.
Drug development > United States.
Drugs > Testing.
Pharmaceutical industry > United States.
Business and medicine > United States.
Drugs > Design.
Pharmaceutical industry.
Randomized Controlled Trials as Topic > United States > Congresses.
Clinical Trials as Topic > United States > Congresses.
Drug Design > United States > Congresses.
Drug Industry > United States > Congresses.
Clinical Trials as Topic
Drug Design
Randomized Controlled Trials as Topic
Drug Industry
Études cliniques > États-Unis.
Études cliniques > Aspect économique > États-Unis.
Études cliniques > Aspect social > États-Unis.
Médicaments > Développement > États-Unis.
Médicaments > Essais cliniques.
Industrie pharmaceutique > États-Unis.
Affaires et médecine > États-Unis.
Médicaments > Conception.
Industrie pharmaceutique.
Drug development.
Business and medicine.
Clinical trials.
United States
United States.
Conference papers and proceedings.
Congress
Actes de congrès.
Acceso en línea:Texto completo
Descripción
Sumario:"There is growing recognition that the United States' clinical trials enterprise (CTE) faces great challenges. There is a gap between what is desired - where medical care is provided solely based on high quality evidence - and the reality - where there is limited capacity to generate timely and practical evidence for drug development and to support medical treatment decisions. With the need for transforming the CTE in the U.S. becoming more pressing, the IOM Forum on Drug Discovery, Development, and Translation held a two-day workshop in November 2011, bringing together leaders in research and health care. The workshop focused on how to transform the CTE and discussed a vision to make the enterprise more efficient, effective, and fully integrated into the health care system. Key issue areas addressed at the workshop included: the development of a robust clinical trials workforce, the alignment of cultural and financial incentives for clinical trials, and the creation of a sustainable infrastructure to support a transformed CTE. This document summarizes the workshop"--Publisher's description.
Descripción Física:1 online resource (xvi, 232 pages) : illustrations (some color)
Bibliografía:Includes bibliographical references.
ISBN:9780309253154
0309253152
0309253160
9780309253161

Ejemplares similares